A combination treatment based on drug repurposing demonstrates mutation-agnostic efficacy in pre-clinical retinopathy models.
Leinonen H, Zhang J, Occelli LM, Seemab U, Choi EH, L P Marinho LF, Querubin J, Kolesnikov AV, Galinska A, Kordecka K, Hoang T, Lewandowski D, Lee TT, Einstein EE, Einstein DE, Dong Z, Kiser PD, Blackshaw S, Kefalov VJ, Tabaka M, Foik A, Petersen-Jones SM, Palczewski K.
Leinonen H, et al. Among authors: lewandowski d.
Nat Commun. 2024 Jul 15;15(1):5943. doi: 10.1038/s41467-024-50033-5.
Nat Commun. 2024.
PMID: 39009597
Free PMC article.